Saturday 17 October 2026 Export BON’s income statement to Excel — free account

Bon Natural Life Limited

Bon Natural Life Limited’s revenue for fiscal 2025 (year ended September 2025) was $18.7 million, down 21.7% from fiscal 2024.

1.14 0.01 +0.88%

Follow BON

Alert me

Market cap: $9.2M
P/E: 0.9×
Fwd P/E: 4.5×
Dividend yield: —
F-score: 3/9
Altman Z: 0.82
Beneish M: −1.98
Dividend safety: n/a

Overview Business Profile Financial Analysis Income Statement Balance Sheet Cash Flow Metrics & Ratios 10-Q 10-K

Insider Decisions trades per month

	Dec 25			Mar 26			Jun 26			Sep 26
Buy	—	—	—	—	—	—	—	—	—	—	—	—
Sell	—	—	—	—	—	—	—	—	—	—	—	—

Insider Ownership 28.03%

Capital & Financial Ratios $m

Market Cap 9.23

Revenue 57.85

Net Income (1.59)

Free Cash Flow (18.14)

Net Debt (7.22)

Current Ratio 1.83

Debt/Equity 0.04

P/E ratio 0.90

Fwd P/E 4.47

P/S ratio 0.00

P/B ratio 0.00

Past 5Y EPS Growth —

This Y EPS Growth —

Next Y EPS Growth —

Next Y revenue growth 14,588.21%

Next 5Y EPS Growth —

Green and red mark values outside typical ranges. How we judge →

Valuation vs history

EV/Sales, ten years

P/E against its own 10 years 2.62%

10-year low 10-year high

Dividends

Payout Ratio —

Annual Dividend Rate —

Annual Dividend Yield —

	total	individual payouts
2026	Powerpack
2025	Powerpack
2024	Powerpack
2023	Powerpack
2022	Powerpack
2021	Powerpack
2020	Powerpack
2019	Powerpack
2018	Powerpack

predictions special payouts not included in total or ratios

Assets vs Liabilities $m

	2023	2024	2025	Q'26
Cash	0	1	6	9
Receivables	5	12	12	10
Inventory	1	2	3	4
Other	16	21	16	11
	24	40	46	51

	2023	2024	2025	Q'26
Payables	1	3	8	9
ST’ Debt	0	0	1	0
Other	0	0	—	—
	10	16	26	28

Compound Annual Growth %

	10y	5y	3y
Sales	—	0.49%	(14.54%)
Cash Flow	—	(44.35%)	0.00%
Earnings	—	0.00%	0.00%
Book Value	—	39.39%	24.45%

Revenue $m

	Mar	Jun	Sep	Dec	Year
’26	—	—	—	—	—
’25	—	—	—	—	19
’24	—	—	—	—	24
’23	—	—	—	—	30
’22	—	—	—	—	30
’21	—	—	—	—	25
’20	—	—	—	—	18

Fiscal quarters ending in the months shown.

Operating Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	—	—	—	—	—
’25	—	—	—	—	0
’24	—	—	—	—	(8)
’23	—	—	—	—	(1)
’22	—	—	—	—	0
’21	—	—	—	—	4
’20	—	—	—	—	3

Fiscal quarters ending in the months shown.

Free Cash Flow $m

	Mar	Jun	Sep	Dec	Year
’26	—	—	—	—	—
’25	(4)	—	(4)	—	(10)
’24	(2)	—	(8)	—	(8)
’23	(2)	—	(1)	—	(1)
’22	(4)	—	(5)	—	(5)
’21	2	—	0	—	(1)
’20	1	—	(2)	—	(2)

Fiscal quarters ending in the months shown.

EPS $

	Mar	Jun	Sep	Dec	Year
’26	—	—	—	—	—
’25	—	—	—	—	(0.72)
’24	—	—	—	—	4.25
’23	—	—	—	—	125.00
’22	—	—	—	—	185.00
’21	—	—	—	—	170.00
’20	—	—	—	—	148.64

Fiscal quarters ending in the months shown.

Group	Line	2016	2017	2018	2019	2020	2021	2022	2023	2024	2025	2026e
Price, $
Price, $	Low	—	—	—	—	—	1,002.50	232.50	87.50	30.75	1.14	Analyst estimates 2026–2028 Powerpack
	High	—	—	—	—	—	4,400.00	1,617.25	645.00	150.00	73.75
People
People	Employees	—	—	—	—	87	93	103	96	97	96
	Revenue/emp, $m	—	—	0.00	0.00	0.21	0.27	0.29	0.31	0.25	0.19
Income, $m
Income, $m	Revenue	—	—	16	16	18	25	30	30	24	19
	Gross margin, %	—	—	32.22	32.22	28.55	27.90	31.51	29.94	29.82	20.77
	EBT	—	—	3	(2)	4	5	8	6	1	(2)
	EBT margin, %	—	—	18.23	0.00	20.06	21.30	25.11	18.88	3.00	(9.16)
	Net income	—	0	0	0	3	5	6	5	0	(2)
	Depreciation	—	—	0	0	0	0	1	1	1	1
Per share, $
Per share, $	Revenue	—	—	0.00	792.08	875.96	962.06	895.47	806.62	249.68	6.78
	Earnings	—	—	0.03	123.99	148.64	172.50	187.50	125.00	4.25	(0.72)
	Cash flow	—	—	0.03	343.23	127.07	152.95	(5.60)	(17.81)	(80.88)	0.05
	Capex	—	—	0.00	(341.78)	(208.32)	(179.39)	(141.74)	(19.98)	(0.07)	(3.63)
	Free cash flow	—	—	0.03	1.44	(81.25)	(26.45)	(147.34)	(37.79)	(80.95)	(3.58)
	Book value	—	—	0.00	350.88	529.95	1,001.31	900.97	983.11	464.39	21.05
	Shares, m	—	—	8	0	0	0	0	0	0	3
Valuation, ×
Valuation, ×	P/E	—	—	2,142.86	2,142.86	2,142.86	2,326.92	415.96	79.96	38.69	1.55
	P/S	—	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	P/B	—	—	0.00	0.00	0.00	0.00	0.00	0.00	0.00	0.00
	EV/Sales	—	—	0.09	0.09	0.09	(0.02)	0.03	0.02	0.01	(0.07)
	EV/FCF	—	—	0.28	0.28	0.28	0.14	(0.21)	(0.11)	(0.06)	0.24
Cash, $m
Cash, $m	Operating cash flow	—	—	0	7	3	4	0	(1)	(8)	0
	Capex	—	—	(2)	(7)	(4)	(5)	(5)	(1)	0	(10)
	Free cash flow	—	—	0	0	(2)	(1)	(5)	(1)	(8)	(10)
Balance, $m
Balance, $m	Working capital	—	—	(2)	6	(1)	9	8	15	23	19
	Total debt	—	—	1	3	4	3	3	1	1	2
	Net debt	—	—	1	3	4	(1)	2	1	1	(4)
	Shareholders’ equity	—	—	7	7	11	27	30	36	44	58
Returns, %
Returns, %	ROA	—	—	13.16	23.90	19.54	14.90	16.93	10.97	0.74	(2.71)
	ROIC	—	—	27.61	0.00	14.77	13.20	12.81	9.98	2.59	(1.89)
	ROE	—	—	108.67	0.00	33.10	24.45	22.03	13.91	0.99	(3.90)

Negative figures in brackets.

All 10 years →

Fiscal years to Sep 2025 · latest quarter Jan 0001 · fundamentals updated 28 Sep 2026

Charts ten years each

Company	Market cap	P/E	Fwd P/E	Revenue growth (Q)	EPS growth (Q)	FCF growth (Q)	Gross margin (Q)	EBIT margin (Q)	Compare
CITR CitroTech Inc.	$68.2M	— (loss-making)	—	−59.18% (below 0%: shrinking)	n/m	−30.95% (below 0%: shrinking)	3.21%	(1,244.78%)	Compare
LOOP Loop Industries, Inc.	$18.0M	— (loss-making)	— (loss-making)	−98.34% (below 0%: shrinking)	n/m	+60.46% (above 0%: growing)	0.00%	(1,463.69%)	Compare
TSEOQ Trinseo PLC	$9.5M	— (loss-making)	— (loss-making)	+7.79% (above 0%: growing)	n/m	−4,036.67% (below 0%: shrinking)	11.79%	0.01%	Compare
BON Bon Natural Life Limited	$9.2M	0.9×	4.5×	+20.95% (above 0%: growing)	−14.29% (below 0%: shrinking)	−260.38% (below 0%: shrinking)	33.34%	0.00%
YMAT J-Star Holding Co., Ltd	$6.1M	—	—	—	—	—	—	—	Compare
CRKN Crown Electrokinetics Corp.	$5.8M	— (loss-making)	0.3×	+306.45% (above 0%: growing)	n/m	−362.52% (below 0%: shrinking)	(36.69%)	(357.14%)	Compare
SNES Senestech, Inc.	$3.8M	— (loss-making)	— (loss-making)	+23.20% (above 0%: growing)	n/m	−42.77% (below 0%: shrinking)	73.64%	(241.82%)	Compare
BGLC BioNexus Gene Lab Corp.	$3.6M	— (loss-making)	—	−96.63% (below 0%: shrinking)	n/m	+44.32% (above 0%: growing)	17.06%	(342.78%)	Compare
CNEY CN Energy Group. Inc.	$3.3M	2.3×	1.1×	−99.90% (below 0%: shrinking)	+33.33% (above 0%: growing)	−113.57% (below 0%: shrinking)	3.28%	0.00%	Compare
Median of peers	$5.9M	—	—	−59.18%	—	−42.77%	3.28%	(342.78%)

All 60 Specialty Chemicals stocks →

Bon Natural Life Limited (BON) key facts

Concern: Bon Natural Life Limited’s revenue for fiscal 2025 (year ended September 2025) was $18.7 million, down 21.7% from fiscal 2024.
Bon Natural Life Limited (BON) is a Specialty Chemicals company in the Basic Materials sector, listed on Nasdaq.
As of October 16, 2026, BON traded at $1.14, a market capitalization of $9.2 million.
Return on equity was −3.90% and debt-to-equity 0.04.
Its Piotroski F-score is 3 out of 9 and its Altman Z-score is 0.82 (distress zone) for fiscal 2025.

Source: company filings (standardised) and stockrow calculations · fundamentals updated Sep 28, 2026.